Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Incontinence, prolapse & sacral neuromodulation · Florida | Incontinence, prolapse & sacral neuromodulation · Texas | |
|---|---|---|
| Surgeons, 2024 | 107 | 85 |
| Medicare fee-for-service cases | 6,731 | 6,023 |
| Growth since 2019 (Medicare FFS) | +0.7%/yr | −0.4%/yr |
| Forecast cases (Medicare FFS) | 7,480 in 2030 | 8,340 in 2030 |
| Forecast growth | +1.8%/yr to 2030 | +5.6%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.0 | 2.8 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 30% (+10 pts since 2019) | 24% (+15 pts since 2019) |
| Cases per surgeon | 63 | 71 |
| Top 10 surgeons' share | 30% | 34% |
| Surgeons growing | 13 | 12 |
| New since the base year | 20 | 10 |
| Likely to stop billing it | 25 by 2026 | 19 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $12K | $13K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.